Mindlessly tinkering, as you playfully put it, isn't my style. I've merely highlighted that the issues at AGY are far from being resolved. The continual extensions of the commissioning/ramp-up timeframe raise concerns, especially given the uncertainties surrounding the effectiveness of the proposed modifications. It's worth noting that the company initially expected their original design to succeed, and the fact that it didn't adds an element of unpredictability to their current endeavours.
While they've outlined a proposed fix and a plan of action, it's essential to recognise that this doesn't guarantee a flawless execution or the absence of unforeseen challenges. Identifying a solution doesn't preclude the possibility of encountering further issues during implementation, nor does it ensure a timely resolution to avert the need for a capital raise in Q1 2024. The recent update (17 Nov 23) revealed a reliance on additional awaited components, leaving them susceptible to external factors, from equipment deliveries to the performance of external contractors, such as the Italians.
In essence, having a plan is a step forward, but it doesn't automatically translate into a comprehensive fix. Caution is warranted as the company navigates these complexities.
As you say, tick-tock.
- Forums
- ASX - By Stock
- AGY
- General Discussion AGY
General Discussion AGY, page-19940
-
- There are more pages in this discussion • 3,320 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
|
|||||
Last
8.5¢ |
Change
-0.008(8.60%) |
Mkt cap ! $123.7M |
Open | High | Low | Value | Volume |
9.0¢ | 9.3¢ | 8.5¢ | $362.9K | 4.093M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 459867 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 93664 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 459867 | 0.085 |
3 | 99873 | 0.084 |
4 | 169062 | 0.083 |
3 | 336585 | 0.082 |
2 | 114691 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 93664 | 1 |
0.088 | 232558 | 1 |
0.089 | 69615 | 2 |
0.090 | 91167 | 2 |
0.091 | 52101 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online